Anxiolytic-like effects of substance P administration into the dorsal, but not ventral, hippocampus and its influence on serotonin

Peptides

Volumn 29, Issue 7, 2008, Pages 1191-1200

  Carvalho, M C ^a,b   Masson, S ^b   Brandao M L ^a,b   de Souza Silva, M A ^c  

^a Instituto de Neurociencias and Comportamento INeC   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Anxiety; Dorsal hippocampus; Elevated plus maze; Rat; Substance P; Ventral hippocampus

Indexed keywords

MONOAMINE; NEUROKININ DERIVATIVE; SEROTONIN; SUBSTANCE P;

ANALYSIS OF VARIANCE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HISTOPATHOLOGY; IN VIVO STUDY; MALE; MAZE TEST; MICRODIALYSIS; MOTOR ACTIVITY; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; MICRODIALYSIS; MICROINJECTIONS; RATS; RATS, WISTAR; SEROTONIN; SUBSTANCE P;

RATTUS;

EID: 44649163179     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.02.014     Document Type: Article

References (76)

1. Acsady L., Katona I., Gulyas A.I., Shigemoto R., and Freund T.F. Immunostaining for substance P receptor labels GABAergic cells with distinct termination patterns in the hippocampus. J Comp Neurol 378 3 (1997) 320-336
2. Aguiar M.S., and Brandao M.L. Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test. Physiol Behav 60 4 (1996) 1183-1186
3. Andrews N., Hogg S., Gonzalez L.E., and File S.E. 5-HT1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. Eur J Pharmacol 264 3 (1994) 259-264
4. Bannerman D.M., Rawlins J.N., McHugh S.B., Deacon R.M., Yee B.K., Bast T., et al. Regional dissociations within the hippocampus-memory and anxiety. Neurosci Biobehav Rev 28 3 (2004) 273-283
5. Bassi G.S., Nobre M.J., Carvalho M.C., and Brandao M.L. Substance P injected into the dorsal periaqueductal gray causes anxiogenic effects similar to the long-term isolation as assessed by ultrasound vocalizations measurements. Behav Brain Res 182 2 (2007) 301-307
6. Boix F., Sandor P., Nogueira P.J., Huston J.P., and Schwarting R.K. Relationship between dopamine release in nucleus accumbens and place preference induced by substance P injected into the nucleus basalis magnocellularis region. Neuroscience 64 4 (1995) 1045-1055
7. Borhegyi Z., and Leranth C. Distinct substance P- and calretinin-containing projections from the supramammillary area to the hippocampus in rats; a species difference between rats and monkeys. Exp Brain Res 115 2 (1997) 369-374
8. Borhegyi Z., and Leranth C. Substance P innervation of the rat hippocampal formation. J Comp Neurol 384 1 (1997) 41-58
9. Buwalda B., Kole M.H., Veenema A.H., Huininga M., de Boer S.F., Korte S.M., et al. Long-term effects of social stress on brain and behavior: a focus on hippocampal functioning. Neurosci Biobehav Rev 29 1 (2005) 83-97
10. Carvalho M.C., Albrechet-Souza L., Masson S., and Brandao M.L. Changes in the biogenic amine content of the prefrontal cortex, amygdala, dorsal hippocampus, and nucleus accumbens of rats submitted to single and repeated sessions of the elevated plus-maze test. Braz J Med Biol Res 38 12 (2005) 1857-1866
11. Davidson T.L., and Jarrard L.E. The hippocampus and inhibitory learning: a 'Gray' area?. Neurosci Biobehav Rev 28 3 (2004) 261-271
12. de Araujo J.E., Huston J.P., and Brandao M.L. Opposite effects of substance P fragments C (anxiogenic) and N (anxiolytic) injected into dorsal periaqueductal gray. Eur J Pharmacol 432 1 (2001) 43-51
13. de Araujo J.E., Silva R.C., Huston J.P., and Brandao M.L. Anxiogenic effects of substance P and its 7-11 C terminal, but not the 1-7 N terminal, injected into the dorsal periaqueductal gray. Peptides 20 12 (1999) 1437-1443
14. Degroot A., and Treit D. Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests. Brain Res 949 1/2 (2002) 60-70
15. Dreifuss J.J., and Raggenbass M. Tachykinins and bombesin excite non-pyramidal neurones in rat hippocampus. J Physiol 379 (1986) 417-428
16. Dringenberg H.C., Levine Y., and Menard J.L. Electrical stimulation of dorsal, but not ventral hippocampus reduces behavioral defense in the elevated plus maze and shock-probe burying test in rats. Behav Brain Res 186 1 (2008) 143-147
17. Duarte F.S., Testolin R., and De Lima T.C. Further evidence on the anxiogenic-like effect of substance P evaluated in the elevated plus-maze in rats. Behav Brain Res 154 2 (2004) 501-510
18. Eichenbaum H. A cortical-hippocampal system for declarative memory. Nat Rev Neurosci 1 1 (2000) 41-50
19. Eichenbaum H. Hippocampus: cognitive processes and neural representations that underlie declarative memory. Neuron 44 1 (2004) 109-120
20. Engin E., and Treit D. The anxiolytic-like effects of allopregnanolone vary as a function of intracerebral microinfusion site: the amygdala, medial prefrontal cortex, or hippocampus. Behav Pharmacol 18 5/6 (2007) 461-470
21. Engin E., and Treit D. The role of hippocampus in anxiety: intracerebral infusion studies. Behav Pharmacol 18 5/6 (2007) 365-374
22. File S.E., and Gonzalez L.E. Anxiolytic effects in the plus-maze of 5-HT1A-receptor ligands in dorsal raphe and ventral hippocampus. Pharmacol Biochem Behav 54 1 (1996) 123-128
23. File S.E., Kenny P.J., and Cheeta S. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol Biochem Behav 66 1 (2000) 65-72
24. Gray J.A., and McNaughton N. Comparison between the behavioural effects of septal and hippocampal lesions: a review. Neurosci Biobehav Rev 7 2 (1983) 119-188
25. Hasenohrl R.U., Jentjens O., de Souza Silva M.A., Tomaz C., and Huston J.P. Anxiolytic-like action of neurokinin substance P administered systemically or into the nucleus basalis magnocellularis region. Eur J Pharmacol 354 2/3 (1998) 123-133
26. Hasenohrl R.U., de Souza-Silva M.A., Nikolaus S., Tomaz C., Brandao M.L., Schwarting R.K., et al. Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery. Neuropeptides 34 5 (2000) 272-280
27. Herpfer I., and Lieb K. Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential. CNS Drugs 19 4 (2005) 275-293
28. Hokfelt T., Bartfai T., and Bloom F. Neuropeptides: opportunities for drug discovery. Lancet Neurol 2 8 (2003) 463-472
29. Hokfelt T., Pernow B., and Wahren J. Substance P: a pioneer amongst neuropeptides. J Intern Med 249 1 (2001) 27-40
30. Hritcu L., Clicinschi M., and Nabeshima T. Brain serotonin depletion impairs short-term memory, but not long-term memory in rats. Physiol Behav 91 5 (2007) 652-657
31. Huston J.P., and Hasenohrl R.U. The role of neuropeptides in learning: focus on the neurokinin substance P. Behav Brain Res 66 1/2 (1995) 117-127
32. Kart E., Jocham G., Muller C.P., Schlomer C., Brandao M.L., Huston J.P., et al. Neurokinin-1 receptor antagonism by SR140333: enhanced in vivo ACh in the hippocampus and promnestic post-trial effects. Peptides 25 11 (2004) 1959-1969
33. Kart-Teke E., Dere E., Brandao M.L., Huston J.P., and de Souza Silva M.A. Reinstatement of episodic-like memory in rats by neurokinin-1 receptor antagonism. Neurobiol Learn Mem 87 3 (2007) 324-331
34. Keck M.E., Sartori S.B., Welt T., Muller M.B., Ohl F., Holsboer F., et al. Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment. J Neurochem 92 5 (2005) 1170-1179
35. Kenny P.J., Cheeta S., and File S.E. Anxiogenic effects of nicotine in the dorsal hippocampus are mediated by 5-HT1A and not by muscarinic M1 receptors. Neuropharmacology 39 2 (2000) 300-307
36. Kjelstrup K.G., Tuvnes F.A., Steffenach H.A., Murison R., Moser E.I., and Moser M.B. Reduced fear expression after lesions of the ventral hippocampus. Proc Natl Acad Sci USA 99 16 (2002) 10825-10830
37. Kostowski W., Plaznik A., and Stefanski R. Intra-hippocampal buspirone in animal models of anxiety. Eur J Pharmacol 168 3 (1989) 393-396
38. Kouznetsova M., and Nistri A. Modulation by substance P of synaptic transmission in the mouse hippocampal slice. Eur J Neurosci 10 10 (1998) 3076-3084
39. Maeno H., Kiyama H., and Tohyama M. Distribution of the substance P receptor (NK-1 receptor) in the central nervous system. Brain Res Mol Brain Res 18 1/2 (1993) 43-58
40. Mantyh P.W. Neurobiology of substance P and the NK1 receptor. J Clin Psychiatry 63 Suppl 11 (2002) 6-10
41. Martin S.J., and Clark R.E. The rodent hippocampus and spatial memory: from synapses to systems. Cell Mol Life Sci 64 4 (2007) 401-431
42. McLean S. Do substance P and the NK1 receptor have a role in depression and anxiety?. Curr Pharm Des 11 12 (2005) 1529-1547
43. McNaughton N. Cognitive dysfunction resulting from hippocampal hyperactivity--a possible cause of anxiety disorder?. Pharmacol Biochem Behav 56 4 (1997) 603-611
44. McNaughton N., and Wickens J. Hebb, pandemonium and catastrophic hypermnesia: the hippocampus as a suppressor of inappropriate associations. Cortex 39 4/5 (2003) 1139-1163
45. Menard J., and Treit D. The anxiolytic effects of intra-hippocampal midazolam are antagonized by intra-septal l-glutamate. Brain Res 888 1 (2001) 163-166
46. Meneses A. 5-HT system and cognition. Neurosci Biobehav Rev 23 8 (1999) 1111-1125
47. Netto S.M., and Guimaraes F.S. Role of hippocampal 5-HT1A receptors on elevated plus maze exploration after a single restraint experience. Behav Brain Res 77 1/2 (1996) 215-218
48. Nikolaus S., Huston J.P., and Hasenohrl R.U. The neurokinin-1 receptor antagonist WIN51,708 attenuates the anxiolytic-like effects of ventralpallidal substance P injection. Neuroreport 10 11 (1999) 2293-2296
49. Nikolaus S., Huston J.P., and Hasenohrl R.U. Anxiolytic-like effects in rats produced by ventral pallidal injection of both N- and C-terminal fragments of substance P. Neurosci Lett 283 1 (2000) 37-40
50. Ogier R., and Raggenbass M. Action of tachykinins in the rat hippocampus: modulation of inhibitory synaptic transmission. Eur J Neurosci 17 12 (2003) 2639-2647
51. Pandis C., Sotiriou E., Kouvaras E., Asprodini E., Papatheodoropoulos C., and Angelatou F. Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus. Neuroscience 140 1 (2006) 163-175
52. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates-The new coronal set. 5th ed. (2005), Academic Press, New York
53. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 3 (1985) 149-167
54. Pennefather J.N., Lecci A., Candenas M.L., Patak E., Pinto F.M., and Maggi C.A. Tachykinins and tachykinin receptors: a growing family. Life Sci 74 12 (2004) 1445-1463
55. Pentkowski N.S., Blanchard D.C., Lever C., Litvin Y., and Blanchard R.J. Effects of lesions to the dorsal and ventral hippocampus on defensive behaviors in rats. Eur J Neurosci 23 8 (2006) 2185-2196
56. Peterson G.M., and Shurlow C.L. Morphological evidence for a substance P projection from medial septum to hippocampus. Peptides 13 3 (1992) 509-517
57. Prut L., and Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463 1/3 (2003) 3-33
58. Quartara L., and Maggi C.A. The tachykinin NK1 receptor. Part II. Distribution and pathophysiological roles. Neuropeptides 32 1 (1998) 1-49
59. Rex A., Voigt J.P., and Fink H. Anxiety but not arousal increases 5-hydroxytryptamine release in the rat ventral hippocampus in vivo. Eur J Neurosci 22 5 (2005) 1185-1189
60. Risold P.Y., and Swanson L.W. Structural evidence for functional domains in the rat hippocampus. Science 272 5267 (1996) 1484-1486
61. Rupniak N.M., Webb J.K., Fisher A., Smith D., and Boyce S. The substance P (NK1) receptor antagonist L-760735 inhibits fear conditioning in gerbils. Neuropharmacology 44 4 (2003) 516-523
62. Saffroy M., Torrens Y., Glowinski J., and Beaujouan J.C. Autoradiographic distribution of tachykinin NK2 binding sites in the rat brain: comparison with NK1 and NK3 binding sites. Neuroscience 116 3 (2003) 761-773
63. Schiapparelli L., Del Rio J., and Frechilla D. Serotonin 5-HT receptor blockade enhances Ca(2+)/calmodulin-dependent protein kinase II function and membrane expression of AMPA receptor subunits in the rat hippocampus: implications for memory formation. J Neurochem 94 4 (2005) 884-895
64. Severini C., Improta G., Falconieri-Erspamer G., Salvadori S., and Erspamer V. The tachykinin peptide family. Pharmacol Rev 54 2 (2002) 285-322
65. Sloviter R.S., Ali-Akbarian L., Horvath K.D., and Menkens K.A. Substance P receptor expression by inhibitory interneurons of the rat hippocampus: enhanced detection using improved immunocytochemical methods for the preservation and colocalization of GABA and other neuronal markers. J Comp Neurol 430 3 (2001) 283-305
66. Sotiriou E., Papatheodoropoulos C., and Angelatou F. Differential expression of gamma-aminobutyric acid--a receptor subunits in rat dorsal and ventral hippocampus. J Neurosci Res 82 5 (2005) 690-700
67. Spolidorio P.C., Echeverry M.B., Iyomasa M., Guimaraes F.S., and Del Bel E.A. Anxiolytic effects induced by inhibition of the nitric oxide-cGMP pathway in the rat dorsal hippocampus. Psychopharmacology (Berl) 195 2 (2007) 183-192
68. Squire L.R., and Cave C.B. The hippocampus, memory, and space. Hippocampus 1 3 (1991) 269-271
69. Squire L.R., Wixted J.T., and Clark R.E. Recognition memory and the medial temporal lobe: a new perspective. Nat Rev Neurosci 8 11 (2007) 872-883
70. Stancampiano R., Cocco S., Cugusi C., Sarais L., and Fadda F. Serotonin and acetylcholine release response in the rat hippocampus during a spatial memory task. Neuroscience 89 4 (1999) 1135-1143
71. Stefanski R., Palejko W., Bidzinski A., Kostowski W., and Plaznik A. Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of midazolam and 5-HT1A receptor agonists. Neuropharmacology 32 10 (1993) 977-985
72. Teixeira R.M., Santos A.R., Ribeiro S.J., Calixto J.B., Rae G.A., and De Lima T.C. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice. Eur J Pharmacol 311 1 (1996) 7-14
73. Vertes R.P. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J Comp Neurol 313 4 (1991) 643-668
74. Vertes R.P., Fortin W.J., and Crane A.M. Projections of the median raphe nucleus in the rat. J Comp Neurol 407 4 (1999) 555-582
75. Witter M.P., Naber P.A., van Haeften T., Machielsen W.C., Rombouts S.A., Barkhof F., et al. Cortico-hippocampal communication by way of parallel parahippocampal-subicular pathways. Hippocampus 10 4 (2000) 398-410
76. Zaninetti M., and Raggenbass M. Oxytocin receptor agonists enhance inhibitory synaptic transmission in the rat hippocampus by activating interneurons in stratum pyramidale. Eur J Neurosci 12 11 (2000) 3975-3984